Sensitive and simplified detection of antibiotic influence on the dynamic and versatile changes of fecal short-chain fatty acids

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Zhao, Xiaoya ^a,b   Jiang, Zhenzuo ^a,b   Yang, Fan ^a,b   Wang, Yan ^a,b   Gao, Xiumei ^a   Wang, Yuefei ^a,b   Chai, Xin ^a,b   Pan, Guixiang ^a,b   Zhu, Yan ^a,b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Tianjin International Joint Academy of Biotechnology and Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFDINIR; CHLORIDE; SHORT CHAIN FATTY ACID; ANTIINFECTIVE AGENT; CARBOHYDRATE DIET; CEPHALOSPORIN DERIVATIVE; VOLATILE FATTY ACID;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; EXTRACTION; FATTY ACID ANALYSIS; FECES ANALYSIS; GAS CHROMATOGRAPHY; INTESTINE FLORA; MALE; NONHUMAN; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; ADMINISTRATION AND DOSAGE; ANIMAL; CARBOHYDRATE DIET; CHEMISTRY; DRUG EFFECTS; FECES; FERMENTATION; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; STANDARDS;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEPHALOSPORINS; CHROMATOGRAPHY, GAS; DIETARY CARBOHYDRATES; FATTY ACIDS, VOLATILE; FECES; FERMENTATION; GASTROINTESTINAL MICROBIOME; MALE; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 84999633694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167032     Document Type: Article

References (48)

1. Sako T, Matsumoto K, Tanaka R (1999) Recent progress on research and applications of non-digestible galacto-oligosaccharides. International Dairy Journal 9: 69-80.
2. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227. PMID: 3678950
3. Rasmussen HS, Holtug K, Mortensen PB (1988) Degradation of amino acids to short-chain fatty acids in humans. An in vitro study. Scand J Gastroenterol 23: 178-182. PMID: 3363290
4. Miller TL, Wolin MJ (1996) Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 62: 1589-1592. PMID: 8633856
5. Salonen A, Lahti L, Salojarvi J, Holtrop G, Korpela K, Duncan SH, et al. (2014) Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8: 2218-2230. doi: 10.1038/ismej.2014.63 PMID: 24763370
6. Louis P, Young P, Holtrop G, Flint HJ (2010) Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 12: 304-314. doi: 10.1111/j.1462-2920.2009.02066.x PMID: 19807780
7. Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12: 661-672. doi: 10.1038/nrmicro3344 PMID: 25198138
8. Lagkouvardos I, Klaring K, Heinzmann SS, Platz S, Scholz B, Engel KH, et al. (2015) Gut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men. Mol Nutr Food Res 59: 1614-1628. doi: 10.1002/mnfr.201500125 PMID: 25988339
9. Meyer D, Stasse-Wolthuis M (2009) The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 63: 1277-1289. doi: 10.1038/ejcn.2009.64 PMID: 19690573
10. Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O, et al. (2015) Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology 220: 1161-1169. doi: 10.1016/j.imbio.2015.06. 004 PMID: 26101138
11. Bird AR, Brown IL, Topping DL (2000) Starches, resistant starches, the gut microflora and human health. Curr Issues Intest Microbiol 1: 25-37. PMID: 11709851
12. Nilsson NE, Kotarsky K, Owman C, Olde B (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303: 1047-1052. PMID: 12684041
13. Schneider SM, Girard-Pipau F, Filippi J, Hebuterne X, Moyse D, Hinojosa GC, et al. (2005) Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 11: 6165-6169. doi: 10.3748/wjg.v11.i39.6165 PMID: 16273644
14. Levison ME (1973) Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginsoa and Enterobacteriaceae. Infect Immun 8: 30-35. PMID: 4198102
15. Hoverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin KE, Saxerholt H, et al. (1986) Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 21: 621-626. PMID: 3749800
16. Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62: 67-72. doi: 10.1079/PNS2002207 PMID: 12740060
17. Arboleya S, Sanchez B, Solis G, Fernandez N, Suarez M, Hernández-Barranco AM, et al. (2016) Impact of Prematurity and Perinatal Antibiotics on the Developing Intestinal Microbiota: A Functional Inference Study. Int J Mol Sci 17.
18. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563. doi: 10.1038/nature12820 PMID: 24336217
19. Ketabi A, Dieleman LA, Ganzle MG (2011) Influence of isomalto-oligosaccharides on intestinal microbiota in rats. J Appl Microbiol 110: 1297-1306. doi: 10.1111/j.1365-2672.2011.04984.x PMID: 21338450
20. Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7: 2839-2849. doi: 10.3390/nu7042839 PMID: 25875123
21. van den Bogaard AE, Stobberingh EE (2000) Epidemiology of resistance to antibiotics. Links between animals and humans. Int J Antimicrob Agents 14: 327-335. PMID: 10794955
22. Perez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, et al. (2013) Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62: 1591-1601. doi: 10.1136/gutjnl-2012-303184 PMID: 23236009
23. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375. doi: 10.1128/IAI.01520-08 PMID: 19307217
24. Lagier JC, Million M, Hugon P, Armougom F, Raoult D (2012) Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol 2: 136. doi: 10.3389/fcimb.2012.00136 PMID: 23130351
25. Young VB, Schmidt TM (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42: 1203-1206. doi: 10.1128/JCM.42.3.1203-1206.2004 PMID: 15004076
26. Yassour M, Vatanen T, Siljander H, Hamalainen AM, Harkonen T, Ryhänen SJ, et al. (2016) Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8: 343ra381.
27. Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. (2016) Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8: 343ra382.
28. Yap IK, Li JV, Saric J, Martin FP, Davies H, Wang Y, et al. (2008) Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 7: 3718-3728. doi: 10.1021/pr700864x PMID: 18698804
29. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57: 1605-1615. doi: 10.1136/gut.2007.133603 PMID: 18941009
30. Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, Patel NB, Wheeler ET, Chona DL, et al. (2009) NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem 47 Suppl 1: S36-46.
31. Murase M, Kimura Y, Nagata Y (1995) Determination of portal short-chain fatty acids in rats fed various dietary fibers by capillary gas chromatography. J Chromatogr B Biomed Appl 664: 415-420. PMID: 7780595
32. Tangerman A, Nagengast FM (1996) A gas chromatographic analysis of fecal short-chain fatty acids, using the direct injection method. Anal Biochem 236: 1-8. doi: 10.1006/abio.1996.0123 PMID: 8619472
33. Zheng X, Qiu Y, Zhong W, Baxter S, Su M, et al. (2013) A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics 9: 818-827. doi: 10.1007/s11306-013-0500-6 PMID: 23997757
34. Destandau E, Vial J, Jardya A, Henniona MC, Bonnet D, Lancelin P. et al. (2005) Development and validation of a reversed-phase liquid chromatography method for the quantitative determination of carboxylic acids in industrial reaction mixtures. J Chromatogr A 1088: 49-56. PMID: 16130732
35. van Eijk HM, Bloemen JG, Dejong CH (2009) Application of liquid chromatography-mass spectrometry to measure short chain fatty acids in blood. J Chromatogr B Analyt Technol Biomed Life Sci 877: 719-724. doi: 10.1016/j.jchromb.2009.01.039 PMID: 19230798
36. Arellano M, Jomard P, El Kaddouri S, Roques C, Nepveu F, Couderc F. et al. (2000) Routine analysis of short-chain fatty acids for anaerobic bacteria identification using capillary electrophoresis and indirect ultraviolet detection. J Chromatogr B Biomed Sci Appl 741: 89-100. PMID: 10839136
37. Morrison DJ, Cooper K, Waldron S, Slater C, Weaver LT, Preston T. (2004) A streamlined approach to the analysis of volatile fatty acids and its application to the measurement of whole-body flux. Rapid Commun Mass Spectrom 18: 2593-2600. doi: 10.1002/rcm.1662 PMID: 15468137
38. Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, Jia W, et al. (2009) Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 393: 163-175. doi: 10.1016/j.ab.2009.06.036 PMID: 19573517
39. Zambell KL, Fitch MD, Fleming SE (2003) Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr 133: 3509-3515. PMID: 14608066
40. Cheng HH, Lai MH (2000) Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J Nutr 130: 1991-1995. PMID: 10917913
41. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17: 1519-1528. doi: 10.3748/wjg.v17.i12 PMID: 21472114
42. Scheppach W, Bartram HP, Richter F (1995) Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Cancer 31A: 1077-1080. PMID: 7576995
43. Ruuskanen O (2004) Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. Pediatr Infect Dis J 23: S135-139. doi: 10.1097/01.inf.0000112528.75956.41 PMID: 14770077
44. Park JH, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, et al. (2016) Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids. PLoS One 11: e0156334. doi: 10.1371/journal.pone.0156334 PMID: 27232601
45. Westerbeek EA, Slump RA, Lafeber HN, Knol J, Georgi G, Fetter WP, et al. (2013) The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants. Eur J Clin Microbiol Infect Dis 32: 269-276. doi: 10.1007/s10096-012-1739-y PMID: 22961006
46. Guay DR (2002) Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin. Clin Ther 24: 473-489. PMID: 12017394
47. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, et al. (1987) Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 31: 1939-1947. PMID: 2449865
48. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280. doi: 10.1371/journal. pbio.0060280 PMID: 19018661